Conforms to 93/112/EC and ISO 11014-1
Material Safety Data Sheet
Reacti-Gel™ (HW-65F)
126
0020250 0020251 0020371
CALL CHEMTREC:
800.424.9300
OUTSIDE US:
202.483.7616
11/4/2002
11/8/2002
Product name
Supplier
Manufacturer
Product No.
MSDS#
Validation Date
Print Date
In Case of Emergency
Section 1. Chemical Product and Company Identification
Responsible Name Pierce Administration
Intended Use Refer to the instruction booklet for proper and intended use. Otherwise, contact supplier for specific applications.
Eng
In USA:
In Europe:
Pierce
Perbio Science
P.O. Box 117
Industriezone III
Rockford, IL 61105 Industrielaan 27
USA
9320 Erembodegem-Aalst
815.968.0747 or
Belgium
1.800.874.3723
Tel:+32 53 83 44 04
Fax:+32 53 83 76 38
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
USA
815.968.0747 or
1.800.874.3723
1) Reacti-Gel
0.1-1
Not available.
--
Not controlled under
dsd (Europe).
2) Reacti-Gel
95-98
200-662-2
F, C
R11, R34
Ingredient Name
EC Number
CAS No.
R-Phrases
Substance/Preparation
Preparation
%
Symbol
:
Section 2. Composition, Information on Ingredients
Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.
Emergency Overview
Medical Conditions Aggravated
by Overexposure:
Repeated or prolonged exposure is not known to aggravate medical condition.
Not available.
Overexposure /Signs/Symptoms
Section 3. Hazards Identification
Routes of Entry
Potential Acute Health Effects
Carcinogenic Effects Data
Keep away from heat, sparks and flame. Avoid contact with eyes, skin and clothing. Avoid breathing vapor or mist.
Keep container closed. Use only with adequate ventilation. Wash thoroughly after handling.
Very hazardous in case of eye contact (irritant). Hazardous in case of skin contact (irritant), of ingestion, of inhalation
(lung irritant). Inflammation of the eye is characterized by redness, watering, and itching.
CARCINOGENIC EFFECTS: Classified None. by NIOSH [Reacti-Gel]. Classified A4 (Not classifiable for human or
animal.) by ACGIH [Reacti-Gel].
MUTAGENIC EFFECTS: